[1]
|
Susan, M.S. and Kristen, A.P. (2014) Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome. Clinical Epidemiology, 6, 1-13.
https://doi.org/10.2147/CLEP.S37559
|
[2]
|
Carmina, E. and Lobo, R.A. (1999) Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women. The Journal of Clinical Endocrinology & Metabolism, 84, 1897-1899.
https://doi.org/10.1210/jcem.84.6.5803
|
[3]
|
Preeti, D., Bronwen, J.R., Jim, W., Michael, J.D. and Robert, J.N. (2007) Glucose Tolerance Abnormalities in Australian Women with Polycystic Ovary Syndrome. Medical Journal of Australia, 187, 328-331.
https://doi.org/10.5694/j.1326-5377.2007.tb01273.x
|
[4]
|
Swarnalatha, M. and Abinaya, M.J. (2019) Prevalence of Glucose Abnormalities in Polycystic Ovary Syndrome Women and Evaluating the Efficacy of Fasting Blood Glucose in Detecting These Glucose Abnormalities Compared to Glucose Tolerance Test. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 8, 1751-1756. https://doi.org/10.18203/2320-1770.ijrcog20191544
|
[5]
|
Zhu, J.P., Teng, Y.C., Zhou, J., Lu, W., Tao, M.F. and Jia, W.P. (2013) Increased Mean Glucose Levels in Patients with Polycystic Ovary Syndrome and Hyperandrogenemia as Determined by Continuous Glucose Monitoring. Acta Obstetricia et Gynecologica Scandinavica, 92, 165-171.
|
[6]
|
Patrick, L. and Jacques, B. (2005) Le syndrome des ovaires polykystiques et ses risques métaboliques et vasculaire. Sang Thrombose Vaisseaux, 17, 382-387.
|
[7]
|
Evanthia, D.K. and Andrea, D. (2012) Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications. Endocrine Reviews, 33, 981-1030. https://doi.org/10.1210/er.2011-1034
|
[8]
|
Catherine, G.B., Marie-Claude, B., Andréanne, T. and Jean-Patrice, B. (2010) Insulin and Hyperandrogenism in Women with Polycystic Ovary Syndrome. The Journal of Steroid Biochemistry and Molecular Biology, 122, 42-52.
https://doi.org/10.1016/j.jsbmb.2009.12.010
|
[9]
|
Dewailly, D., Boucher, A. and Merlen, E. (1998) Le Syndromedes ovaires polymicrokystiques. Collège des gynécologues et obstetriciens francais. Extrait des Mises à jour en Gynécologie et Obstétrique-Tome XXII publié, 77-104.
|
[10]
|
Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson, F., Oden, A., Janson, P.O., Mattson, L.A., Crona, N. and Lundberg, PA. (1992) Women with Polycystic Ovary Syndrome Wedge Resected in 1956 to 1965: A Long Term Followup Focusing on Natural History and Circulating Hormones. Fertility and Sterility, 57, 505-513.
|
[11]
|
American Diabetes Association (2018) Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41, 13-27.
https://doi.org/10.2337/dc18-S002
|
[12]
|
Mohsen, R., Nasrin, A., Yasna, P., Mahshid, G. and Shaghayegh, H. (2016) Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology, 29, 562-566. https://doi.org/10.1016/j.jpag.2016.07.001
|
[13]
|
Niels, H.I.H., Tina, K.J., Jens, P.E.B., Tine, B.H., Anna-Maria, A., Niels, E.S. and The Danish First Pregnancy Planner Study Team (1999) Is Glycosylated Haemoglobin a Marker of Fertility? A Follow-up Study of First-Pregnancy Planners. Human Reproduction, 14, 1478-1482. https://doi.org/10.1093/humrep/14.6.1478
|
[14]
|
Rinkoo, D., Liuh, L.G., Xin, T., Daniel, E.K.C. and Bernhard, B. (2018) Total Oxidative Index Is Associated with Glycated Hemoglobin, Low-Grade Inflammation, and Non-HDL Cholesterol in Type 2 Diabetes. Diabetes, 67, 419-425.
https://doi.org/10.2337/db18-419-P
|
[15]
|
D'Souza, J.M., D’Souza, R.P., Vijin, V.F., Shetty, A., Arunachalam, C., Pai, V.R., Shetty, R. and Faarisa, A. (2016) High Predictive Ability of Glycated Hemoglobin on Comparison with Oxidative Stress Markers in Assessment of Chronic Vascular Complications in Type 2 Diabetes Mellitus. Scandinavian Journal of Clinical and Laboratory Investigation, 76, 51-57. https://doi.org/10.3109/00365513.2015.1092048
|
[16]
|
Deepika, G. and Zaher, M. (2015) Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS? Nutrients, 7, 10129-10144.
https://doi.org/10.3390/nu7125524
|
[17]
|
Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A.G. and Panidis D. (2008) Increased Serum Advanced Glycation End-Products Is a Distinct Finding in Lean Women with Polycystic Ovary Syndrome (PCOS). Clinical Endocrinology, 69, 634-641.
https://doi.org/10.1111/j.1365-2265.2008.03247.x
|
[18]
|
Diamanti-Kandarakis, E., Piperi, C., Kalofoutis, A. and Creatsas, G. (2005) Increased Levels of Serum Advanced Glycation End-Products in Women with Polycystic Ovary Syndrome. Clinical Endocrinology, 62, 37-43.
https://doi.org/10.1111/j.1365-2265.2004.02170.x
|
[19]
|
Merhi, Z. (2014) Advanced Glycation End Products and Their Relevance in Female Reproduction. Human Reproduction, 29, 135-145.
https://doi.org/10.1093/humrep/det383
|
[20]
|
Torre, A. and Fernandez, H. (2007) Le syndrome des ovaires polykystiques (SOPK). Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 36, 423-446.
https://doi.org/10.1016/j.jgyn.2007.04.002
|
[21]
|
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Fertility and Sterility, 81, 19-25.
https://doi.org/10.1016/j.fertnstert.2003.10.004
|
[22]
|
Agasa, B., Bosunga, K., Opara, A., Tshilumba, K., Dupont, E., Vertongen, F., Cotton, F. and Gulbis, B. (2007) Prevalence of Sickle Cell Disease in a Northeastern Region of the Democratic Republic of Congo: What Impact on Transfusion Policy? Journal of Medical Screening, 14, 113-116.
|
[23]
|
Mutesa, L., Boemer, F., Ngendahayo, L., Rulisa, S., Rusingiza, E.K., Cwinya-Ay, N., Mazina, D., Kariyo, P.C., Bours, V. and Schoos, R. (2008) Neonatal Screening for Sickle Cell Disease in Central Africa: A Study of 1825 Newborns with a New Enzyme-Linked Immunosorbent Assay Test. Public Health, 122, 933-941.
https://doi.org/10.1258/096914107782066211
|
[24]
|
Arlene, S. (2008) Glycemic Control and Hemoglobinopathy: When A1C May Not Be Reliable. Diabetes Spectrum, 21, 46-49.
https://doi.org/10.2337/diaspect.21.1.46
|
[25]
|
Consensus Committee (2007) American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and International Diabetes Federation (IFD) Consensus Statement on Worldwide Standardization of Hemoglobin A1c Measurement. Biochimica Clinica, 31.
|
[26]
|
American Diabetes Association (2019) Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care, 42, 13-28.
https://doi.org/10.2337/dc19-S002
|
[27]
|
Mbuyamba, N.K.L., Biayi, M.J., Mwembo-Tambwe, N.A. and Kalenga, M.KP. (2014) Etude des aspects cliniques, échographiques et nutritionnels du syndrome des ovaires micropolykystiques (SOMPK) à Mbuji-Mayi, RD du Congo. The Pan African Medical Journal, 19, 267-276.
https://doi.org/10.11604/pamj.2014.19.267.3162
|
[28]
|
Mboloko, E., Mputu, L., Mbuyi-Muamba, J.M. and Mbayo, K. (2004) Prévalence du syndrome des ovaries micropolykystiques chez la Congolaise. Elite Medical, 4, 6-10.
|
[29]
|
Goldzieher, W.J. and Axelrod, L.R. (1983) Clinical and Biochimical Features of Polykysticovarian Disease. Fertility and Sterility, 14, 631-653.
https://doi.org/10.1016/S0015-0282(16)35047-6
|
[30]
|
Susan, S. (2007) Obesity and Polycystic Ovary Syndrome. Obesity Management, 3, 69-73. https://doi.org/10.1089/obe.2007.0019
|
[31]
|
Enrique, R.-M., Carlos, O.-G., Nayeli, M.-C., Lidia, A.-S., Guadalupe, E.-G., Carlos, M., Ana, P.S.-S., Rodolfo, H.-S. and Julio, F.J.-D. (2016) Association of Obesity and Overweight with the Prevalence of Insulin Resistance, Pre-Diabetes and Clinical-Biochemical Characteristics among Infertile Mexican Women with Polycystic Ovary Syndrome: A Cross-Sectional Study. BMJ Open, 6, 1-8.
https://doi.org/10.1136/bmjopen-2016-012107
|
[32]
|
Seda, A., Osman, S., Sinem, S., Banu, D., Fulya, O., Omer, U. and Ramazan, D. (2013) Different Phenotypes of Polycystic Ovary Syndrome in Turkish Women: Clinical and Endocrine Characteristics. Gynecological Endocrinology, 29, 931-935.
https://doi.org/10.3109/09513590.2013.819082
|
[33]
|
Bernard, B., Charles, S. and Christian, J. (2004) Traité de gynécologie médicale. Springer-Verlag France, Paris, 571.
|
[34]
|
Sebastiao, F.M., Marcia, M.W.Y., Herica, B.B., Danilla, B. and Jacklyne, S.B. (2014) Prevalence of Elevated Glycated Hemoglobin Concentrations in the Polycystic Ovary Syndrome: Anthropometrical and Metabolic Relationship in Amazonian Women. Journal of Clinical Medicine Research, 6, 278-286.
|
[35]
|
Jin, J.K., Young, M.C., Young, M.C., Hye, S.J., Soo, J.C., Kyu, R., Hwang, S.S.H., Seung, Y.K., Seok, H.K., Jung, G.K. and Shin, Y.M. (2012) Prevalence of Elevated Glycated Hemoglobin in Women with Polycystic Ovary Syndrome. Human Reproduction, 27, 1439-1444. https://doi.org/10.1093/humrep/des039
|
[36]
|
Renuka, P., Shakthiya, T. and Vinodhini, V.M. (2018) Study of Glycated Hemoglobin Levels in Polycystic Ovary Syndrome. Asian Journal of Pharmaceutical and Clinical Research, 11, 191-193. https://doi.org/10.22159/ajpcr.2018.v11i5.22729
|
[37]
|
Sunita, M.A. and Jayashree, S.B. (2018) Assessment of Glycated Hemoglobin and Uric Acid Level in Polycystic Ovarian Syndrome in a Tertiary Care Institute of Marathwada Region. International Journal of Clinical Biochemistry and Research, 5, 49-53. https://doi.org/10.18231/2394-6377.2018.0011
|
[38]
|
Rezaee, M., Asadi, N., Pouralborz, Y., Ghodrat, M. and Habibi, S. (2016) A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology, 29, 562-566. https://doi.org/10.1016/j.jpag.2016.07.001
|
[39]
|
Jayesh, S., Ankna, S., Frenny, S., Sunil, T., Nutan, N., Navneet, S., Premal, T. and Rama, V. (2015) The Association of Dyslipidemia and Obesity with Glycated Hemoglobin. Clinical Diabetes and Endocrinology, 1, 1-7.
https://doi.org/10.1186/s40842-015-0004-6
|
[40]
|
Masafumi, K., Michio, O., Sueko, M., Hiroshi, S., Mikio, M. and Soji, K. (2007) Negative Association of Obesity and Its Related Chronic Inflammation with Serum Glycated Albumin But Not Glycated Hemoglobin Levels. Clinica Chimica Acta, 378, 48-52. https://doi.org/10.1016/j.cca.2006.10.013
|
[41]
|
Jain, M., Jadeja, J.M. and Mehta, N. (2013) Correlation between HbA1c Values and Lipid Profile in Type 2 Diabetes Mellitus. International Journal of Basic and Applied Physiology, 2, 47-50.
|
[42]
|
Zhang, J., Liu, X.F., Liu, Y., Xu, L.Z., Zhou, L.L., Tang, L.L., et al. (2014) Environmental Risk Factors for Women with Polycystic Ovary Syndrome in China: A Population-Based Case-Control Study. Journal of Biological Regulators & Homeostatic Agents, 28, 203-211.
|
[43]
|
Medeiros, I.C. and Lima, J.G. (2015) Polycystic Ovary Syndrome as an Endogenous Alcoholic Polycystic Ovary Syndrome. Medical Hypotheses, 85, 148-152.
|
[44]
|
Rutkowska, A.Z. and Diamanti-Kandarakis, E. (2016) Polycystic Ovary Syndrome and Environmental Toxins. Fertility and Sterility, 106, 948-958.
https://doi.org/10.1016/j.fertnstert.2016.08.031
|
[45]
|
Richard, S.L., Allen, R.K., William, C.D. and Andrea, D. (1999) Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women. The Journal of Clinical Endocrinology & Metabolism, 84, 165-169.
https://doi.org/10.1210/jc.84.1.165
|
[46]
|
Julie, L.S. (2003) Polycystic Ovary Syndrome and the Metabolic Syndrome. Clinical Diabetes, 21, 154-161. https://doi.org/10.2337/diaclin.21.4.154
|
[47]
|
Alessandra, G., Laura, P., Paola, A., Uberto, P., Carmine, P., Lamberto, M. and Renato, P. (2012) Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results from a Long-Term Prospective Study. Diabetes, 61, 2369-2374.
https://doi.org/10.2337/db11-1360
|
[48]
|
Iván, C.-R., Barbara, P., Celia, á.-B., Fernando, R.-A. and Vicente, M.-V. (2017) Glycated Haemoglobin A1c as a Risk Factor of Cardiovascular Outcomes and All-Cause Mortality in Diabetic and Nondiabetic Populations: A Systematic Review and Meta-Analysis. BMJ Open, 7, 1-11.
https://doi.org/10.1136/bmjopen-2017-015949
|
[49]
|
Oluboyo, A.O., Njoku, J.G. and Oluboyo, B.O. (2017) Relationship between Fertility Hormones and Glycated Haemoglobin in Type 2 Diabetic Subjects. International Journal of Current Research, 9, 55865-55867.
|
[50]
|
Kelly, C.C., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M. and Sattar, N. (2001) Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome. The Journal of Clinical Endocrinology & Metabolism, 86, 2453-2455.
https://doi.org/10.1210/jcem.86.6.7580
|
[51]
|
Escobar-Morreale, H.F., Luque-Ramirez, M. and Gonzalez, F. (2011) Circulating Inflammatory Markers in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Fertility and Sterility, 95, 1048-1058.
https://doi.org/10.1016/j.fertnstert.2010.11.036
|
[52]
|
Antoni, J.D. and Anuja, D. (2012) Is PCOS an Inflammatory Process? Fertility and Sterility, 97, 7-12. https://doi.org/10.1016/j.fertnstert.2011.11.023
|
[53]
|
Liu, S., James, M.H., Robert, J.M.C., Li, S. and Vivian, A. (2015) Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults. The Journal of Clinical Endocrinology & Metabolism, 100, 2364-2371.
https://doi.org/10.1210/jc.2014-4454
|
[54]
|
Wu, T., Dorn, J.P., Donahue, R.P., Sempos, C.T. and Trevisan, M. (2002) Associations of Serum C-Reactive Protein with Fasting Insulin, Glucose and Glycosylated Hemoglobin. American Journal of Epidemiology, 155, 65-71.
https://doi.org/10.1093/aje/155.1.65
|
[55]
|
Sushma, B.J. and Shrikant, C. (2016) Study of Serum High-Sensitivity C-Reactive Protein, Ferritin and Glycated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus. International Journal of Science and Research (IJSR), 5, 2177-2182.
https://doi.org/10.21275/v5i6.NOV164805
|
[56]
|
Mortada, R., Kallail, J.K., Dong, F. and Sidika, K. (2015) HbA1c in Patients with Polycystic Ovary Syndrome: A Potential Marker of Inflammation. Journal of Reproduction & Infertility, 16, 203-206.
|
[57]
|
Rutkowska, A.Z. and Diamanti-Kandarakis, E. (2016) Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)? Current Pharmaceutical Design, 22, 5558-5571.
https://doi.org/10.2174/1381612822666160714094404
|
[58]
|
Evangelia, T., Christina, P., Sarantis, L., Anastasios, K., Christos, A., Aikaterini, K., Charikleia, C. and Evanthia, D.-K. (2014) Impact of Dietary Modification of Advanced Glycation End Products (AGEs) on the Hormonal and Metabolic Profile of Women with Polycystic Ovary Syndrome (PCOS). Hormones, 13, 65-73.
https://doi.org/10.1007/BF03401321
|
[59]
|
Zhang, J.J. and Merhi, Z. (2016) Could Advanced Glycation End Products Explain the Poor Response to Controlled Ovarian Hyperstimulation in Obese Women? Journal of Endocrinology and Diabetes, 3, 1-9.
https://doi.org/10.15226/2374-6890/3/2/00146
|